Kelvin Health has signed a non-dilutive grant funding agreement for state support amounting to $2.9M. The financing will be used over two consecutive years to boost the company’s R&D, regulatory and early market access activities. The news comes shortly after Kelvin Health graduated from the MedTech Innovator US market access program in June–November 2025. The company is on a mission to prevent complications from conditions like artery disease through accessible early diagnostics.
Kelvin Health has signed a non-dilutive grant funding agreement for state support amounting to $2.9M
